LOXO-292
Showing 1 - 25 of 63
Healthy Trial in Madison ([14C] Selpercatinib, Selpercatinib)
Completed
- Healthy
- [14C] Selpercatinib
- Selpercatinib
-
Madison, WisconsinLabCorp CRU, Inc.
Nov 21, 2022
Healthy Trial in Madison (Selpercatinib, Ranitidine, Omeprazole)
Completed
- Healthy
- Selpercatinib
- +2 more
-
Madison, WisconsinCovance Clinical Research Unit, Inc.
Jan 12, 2023
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
Healthy Trial in Dallas (Rosuvastatin, Selpercatinib)
Not yet recruiting
- Healthy
-
Dallas, TexasLabcorp Clinical Research LP
Jun 8, 2023
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa
Recruiting
- Lung Non-Small Cell Carcinoma
- +4 more
- Carboplatin
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Aug 16, 2022
Healthy Trial in Singapore (Selpercatinib)
Completed
- Healthy
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Jul 12, 2022
Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)
Active, not recruiting
- Solid Tumor
- Medullary Thyroid Cancer
-
Guangzhou, Guangdong, China
- +12 more
May 9, 2022
NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)
Recruiting
- Non-Small Cell Lung Cancer
- +3 more
- LOXO-292
-
Scottsdale, Arizona
- +84 more
Oct 10, 2022
Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +37 more
-
Birmingham, Alabama
- +171 more
Aug 24, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)
Recruiting
- Medullary Thyroid Cancer
- Selpercatinib
- +2 more
-
Birmingham, Alabama
- +148 more
Jan 18, 2023
Healthy Trial in Madison ([¹4C]-LOXO-783, LOXO-783)
Not yet recruiting
- Healthy
-
Madison, WisconsinFortrea Clinical Research
Oct 23, 2023